Purchase Order 75D30123P17288
Award Date
9/21/23
Potential Completion Date
11/1/24
Potential Value
$102K
Federal Agency
CDC Pittsburgh
Awardee
Luminex Corp
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $77,468.82 firm fixed price purchase order to Luminex Corporation for MAGPIX and reagent lab supplies. The CDC, located within the Department of Health and Human Services, will utilize these products to support its infectious disease prevention and control programs conducted from its Pittsburgh location. Luminex will deliver the requested supplies from its production facilities in Austin, Texas by October 27, 2023 to meet the CDC's...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
The Centers for Disease Control and Prevention (CDC) awarded a $79,711 firm-fixed-price purchase order contract to Luminex Corporation for annual services. The contract has an ultimate completion date of April 30, 2026. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and often serves as a prime contractor delivering specialized multiplexing systems to federal agencies. This contract is not designated as a set-aside requirement. Luminex...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $20,700 firm fixed price delivery order against the Multiple Award Schedule to Luminex Corporation for the purchase of laboratory equipment. The award, made on February 19, 2020, does not have a set-aside designation and calls for delivery of the equipment by May 18, 2020. Luminex will provide the equipment to the CDC from its place of performance in Austin, Texas to support the agency's...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
This is a $7,717 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the provision of a LUMINEX 200 service and does not have a set-aside designation. Luminex often serves as a prime contractor delivering specialized multiplexing systems that support clinical testing programs and biomedical research efforts across federal agencies,...
This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...
This federal contract award is for a LUMINEX GUAVA SYSTEM, valued at $94,312.30, and was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The contract was awarded to Luminex Corporation, a manufacturer of biological testing technologies, including multiplex diagnostic solutions for clinical laboratories and life science research settings. The contract is a firm fixed-price purchase order and is not a set-aside. Luminex has provided various diagnostic testing...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...